Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | BMY | AMGN | MRNA | GILD |
| Company | Apellis Pharmaceuticals Inc | Bristol-Myers Squibb Company | Amgen Inc | Moderna Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 47.52 | 48.21 | 264.63 | 102.37 | 66.25 |
| High | 48.19 | 49.05 | 269.38 | 103.79 | 66.83 |
| Low | 46.53 | 48.12 | 260.68 | 100.45 | 66.16 |
| Last | 47.53 | 48.93 | 268.93 | 101.41 | 66.76 |
| Change | +0.02 | +0.63 | +6.18 | -0.59 | +0.60 |
| % Change | +0.04% | +1.30% | +2.35% | -0.58% | +0.91% |
| Volume | 1,179,300 | 10,303,900 | 3,380,300 | 2,670,400 | 10,657,000 |
| 20-Day Average Volume | 1,191,705 | 11,303,500 | 2,246,435 | 3,263,940 | 6,455,920 |
| Previous Close | 47.51 | 48.30 | 262.75 | 102.00 | 66.16 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 54.56 | 50.85 | 272.56 | 105.32 | 69.90 |
| 20-Day Raw Stochastic | 8.36% | 19.17% | 29.59% | 23.35% | 10.79% |
| 20-Day Relative Strength | 33.17% | 41.16% | 43.95% | 48.14% | 31.30% |
| Weighted Alpha | -16.26 | -28.90 | +7.67 | -20.42 | -24.32 |
| Today's Opinion | 40% Sell | 72% Sell | 56% Sell | 72% Buy | 100% Sell |
| Previous Opinion | 40% Sell | 72% Sell | 56% Sell | 72% Buy | 100% Sell |
| Last Month's Opinion | 8% Buy | 24% Sell | 8% Sell | 56% Buy | 72% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.23% since 04/12/24 | +1.35% since 04/12/24 | +0.62% since 04/12/24 | -3.55% since 04/12/24 | -1.92% since 04/12/24 |
| Low | 46.40 on 04/18/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 99.90 on 04/18/24 | 65.90 on 04/18/24 |
| High | 53.06 on 04/16/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 106.42 on 04/16/24 | 68.46 on 04/15/24 |
| 1-Month | |||||
| %Chg | -16.50% since 03/19/24 | -5.54% since 03/19/24 | -1.03% since 03/19/24 | -3.52% since 03/19/24 | -9.06% since 03/19/24 |
| Low | 46.40 on 04/18/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 97.00 on 04/03/24 | 65.90 on 04/18/24 |
| High | 59.91 on 04/01/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 115.89 on 04/09/24 | 74.28 on 03/21/24 |
| 3-Month | |||||
| %Chg | -25.50% since 01/19/24 | -2.35% since 01/19/24 | -12.63% since 01/19/24 | +1.72% since 01/19/24 | -23.52% since 01/19/24 |
| Low | 46.40 on 04/18/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 84.06 on 02/13/24 | 65.90 on 04/18/24 |
| High | 71.90 on 02/26/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 115.89 on 04/09/24 | 81.06 on 01/25/24 |
| 6-Month | |||||
| %Chg | +2.92% since 10/19/23 | -13.37% since 10/19/23 | -4.16% since 10/19/23 | +23.12% since 10/19/23 | -14.89% since 10/19/23 |
| Low | 41.19 on 11/06/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 62.55 on 11/02/23 | 65.90 on 04/18/24 |
| High | 73.80 on 01/09/24 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 115.97 on 01/08/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,728,851 | 97,892,464 | 140,812,720 | 39,053,760 | 82,374,304 |
| Shares Outstanding, K | 120,582 | 2,026,759 | 535,919 | 382,880 | 1,245,077 |
| Annual Sales | 396,590,000 | 45,006,000,000 | 28,190,000,000 | 6,848,000,000 | 27,116,000,000 |
| Annual Net Income | -528,630,000 | 8,025,000,000 | 6,717,000,000 | -4,714,000,000 | 5,665,000,000 |
| Last Quarter Sales | 146,380,000 | 11,477,000,000 | 8,196,000,000 | 2,811,000,000 | 7,114,000,000 |
| Last Quarter Net Income | -88,580,000 | 1,762,000,000 | 767,000,000 | 217,000,000 | 1,429,000,000 |
| 60-Month Beta | 0.88 | 0.39 | 0.58 | 1.62 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 02/27/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 0.55 on 02/22/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 05/02/24 | 04/25/24 | 05/02/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | N/A | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | N/A | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 14.16 | 0.00 | 9.96 |